Tomorrow's ISMP Mediation Safety Alert! notes an FDA alert for healthcare professionals about Wallcur, LLC, simulated intravenous (IV) products in human or animal patients. This is an update to an earlier alert on 12/30/14. There have been serious adverse events associated with misuse of Wallcur demonstration products. More than 40 patients actually received these solutions IV or locally and developed chills and/or sepsis; 1 patient died. One of the products, Practi-0.9% Sodium Chloride 100 mL, contains distilled water, not sterile saline, so hemolysis also might be an issue.